PET/Computed Tomography in Breast Cancer: Can It Aid in Developing a Personalized Treatment Design?

Malapure, Sumeet S (2016) PET/Computed Tomography in Breast Cancer: Can It Aid in Developing a Personalized Treatment Design? PET Clinics, 11 (3). pp. 297-303.

[img] PDF
RMS - 00002908.pdf - Published Version
Restricted to Registered users only

Download (61kB) | Request a copy

Abstract

PET with fluorodeoxyglucose (FDG-PET)/computed tomography (CT) imaging has significantly improved the management of breast cancer. FDG, however, is not tumor-specific and various image interpretation pitfalls may occur due to false-positive and false-negative causes of FDG uptake. PET/CT imaging with more specific radiopharmaceuticals may provide useful information about the pathophysiology in such cases. In the present article, we reviewed the use of whole-body FDG-PET/CT and (18)F-16α-17β-Fluoroestradiol PET/CT imaging to determine if these can be used to develop personalized treatment design for the better management of breast cancer.

Item Type: Article
Uncontrolled Keywords: Breast cancer; Receptor imaging; 18 F-FDG PET/CT; 18 F-16α-17β-Fluoroestradiol PET/CT.
Subjects: Medicine > KMC Manipal > Nuclear Medicine
Depositing User: KMC Library
Date Deposited: 17 Jul 2017 03:49
Last Modified: 17 Jul 2017 03:49
URI: http://eprints.manipal.edu/id/eprint/149367

Actions (login required)

View Item View Item